D. C. GÜVEN Et Al. , "SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research," ONCOLOGIST , vol.27, no.11, 2022
GÜVEN, D. C. Et Al. 2022. SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research. ONCOLOGIST , vol.27, no.11 .
GÜVEN, D. C., Sahin, T. K., AKIN, S., & Uckun, F. M., (2022). SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research. ONCOLOGIST , vol.27, no.11.
GÜVEN, DENİZ Et Al. "SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research," ONCOLOGIST , vol.27, no.11, 2022
GÜVEN, DENİZ C. Et Al. "SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research." ONCOLOGIST , vol.27, no.11, 2022
GÜVEN, D. C. Et Al. (2022) . "SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research." ONCOLOGIST , vol.27, no.11.
@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research}, journal={ONCOLOGIST}, year=2022}